Page last updated: 2024-08-18

3-hydroxybutanal and Cancer of Prostate

3-hydroxybutanal has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaur, J; Khatik, GL; Kumar, V; Nair, VA; Tikoo, K; Venugopalan, P	1

Other Studies

1 other study(ies) available for 3-hydroxybutanal and Cancer of Prostate

Article	Year
Aldol derivatives of Thioxoimidazolidinones as potential anti-prostate cancer agents. European journal of medicinal chemistry, 2011, Volume: 46, Issue:8 Topics: Aldehydes; Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Imidazolidines; Male; Models, Molecular; Molecular Conformation; Prostate; Prostatic Neoplasms; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Sulfhydryl Compounds	2011

Article

Year

Aldol derivatives of Thioxoimidazolidinones as potential anti-prostate cancer agents.

European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

Topics: Aldehydes; Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Imidazolidines; Male; Models, Molecular; Molecular Conformation; Prostate; Prostatic Neoplasms; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship; Sulfhydryl Compounds

2011